We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+11.43%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$43.4B
AUM Growth
+$3.14B
(+7.8%)
Cap. Flow
-$115M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
13.22%
Holding
2,192
New
164
Increased
795
Reduced
936
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$193M |
| 2 |
Gilead Sciences
GILD
|
+$115M |
| 3 |
Tencent Music
TME
|
+$83.5M |
| 4 |
Kanzhun
BZ
|
+$76.7M |
| 5 |
Wheaton Precious Metals
WPM
|
+$68.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$189M |
| 2 |
Williams Companies
WMB
|
+$155M |
| 3 |
AYX
Alteryx Inc
AYX
|
+$94.1M |
| 4 |
AbbVie
ABBV
|
+$87M |
| 5 |
Amgen
AMGN
|
+$78.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.44% |
| 2 | Healthcare | 17.1% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 10.38% |
| 5 | Consumer Discretionary | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Merit Medical Systems
MMSI
$5.15B
| $13.9K | ﹤0.01% |
+184
| New | +$14.2K |
|
1752
Veracyte
VCYT
$3.09B
| $13.8K | ﹤0.01% |
+625
| New | +$15.2K |
|
1753
Invesco
IVZ
$13.2B
| $13.6K | ﹤0.01% |
821
-300
| -27% | -$4.84K |
|
1754
Viant Technology
DSP
$260M
| $13.4K | ﹤0.01% |
1,258
| – | – |
|
1755
iShares MSCI Japan ETF
EWJ
$23.2B
| $13.3K | ﹤0.01% |
187
| – | – |
|
|
TPH
1756
DELISTED
Tri Pointe Homes
TPH
| $13.3K | ﹤0.01% |
345
+2
| +0.6% | +$70 |
|
1757
Toyota
TM
$227B
| $13.1K | ﹤0.01% |
52
+5
| +11% | +$1.11K |
|
1758
Entrada Therapeutics
TRDA
$267M
| $12.6K | ﹤0.01% |
888
-20
| -2% | -$283 |
|
1759
Healthcare Services Group
HCSG
$1.5B
| $12.4K | ﹤0.01% |
993
-47,949
| -98% | -$532K |
|
|
REFI
1760
Chicago Atlantic Real Estate Finance
REFI
$283M
| $12K | ﹤0.01% |
761
| – | – |
|
1761
Embecta
EMBC
$290M
| $11.9K | ﹤0.01% |
900
+752
| +508% | +$11.6K |
|
1762
Tyra Biosciences
TYRA
$1.46B
| $11.7K | ﹤0.01% |
713
-1,357
| -66% | -$22.3K |
|
1763
Shinhan Financial Group
SHG
$38.1B
| $11.7K | ﹤0.01% |
329
| – | – |
|
1764
ABM Industries
ABM
$2.94B
| $11.6K | ﹤0.01% |
+261
| New | +$10.9K |
|
|
KLRS
1765
Kalaris Therapeutics
KLRS
$75M
| $11.5K | ﹤0.01% |
661
+576
| +678% | +$9.4K |
|
|
AIV
1766
Aimco
AIV
$330M
| $11.2K | ﹤0.01% |
1,371
-5,802
| -81% | -$44.3K |
|
|
TVRD
1767
Tvardi Therapeutics
TVRD
$23.3M
| $11.2K | ﹤0.01% |
341
-22,766
| -99% | -$590K |
|
1768
Third Coast Bancshares
TCBX
$734M
| $11.1K | ﹤0.01% |
556
+409
| +278% | +$7.92K |
|
|
ALLK
1769
DELISTED
Allakos
ALLK
| $11K | ﹤0.01% |
+8,720
| New | +$13.5K |
|
|
PRSU
1770
Pursuit Attractions and Hospitality Inc
PRSU
$1.33B
| $10.7K | ﹤0.01% |
272
+211
| +346% | +$7.34K |
|
1771
Security National Financial
SNFCA
$228M
| $10.6K | ﹤0.01% |
1,548
| – | – |
|
1772
Beazer Homes USA
BZH
$891M
| $10.4K | ﹤0.01% |
316
-603
| -66% | -$18.6K |
|
1773
Aclaris Therapeutics
ACRS
$773M
| $10.2K | ﹤0.01% |
8,259
+3,676
| +80% | +$4.38K |
|
|
CIO
1774
DELISTED
City Office REIT
CIO
| $10.2K | ﹤0.01% |
1,953
-162,897
| -99% | -$821K |
|
1775
EverQuote
EVER
$826M
| $10.1K | ﹤0.01% |
+545
| New | +$8K |
|
Similar funds
Federated Hermes's Q1 2024 Portfolio in Review
As of Q1 2024, Federated Hermes held 2,192 positions worth $43.4B, up 7.8% from $40.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q1 2024 filing shows 164 new, 795 increased, 936 reduced and 172 closed positions. Its largest new stake was Kanzhun: 4,861,533 shares worth $85.2M. The largest sale was Medtronic, an estimated $189M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q1 2024 buy was Kanzhun: 4,861,533 shares worth $85.2M.
- Federated Hermes added most to Bristol-Myers Squibb in Q1 2024, an estimated $193M increase.
- Federated Hermes's biggest Q1 2024 reduction was Medtronic, cutting an estimated $189M.
- Federated Hermes fully exited Alteryx Inc in Q1 2024, selling an estimated $94.1M.
- Federated Hermes's ten largest holdings make up 13% of its $43.4B portfolio in Q1 2024.
- Federated Hermes opened 164 new positions and closed 172 in Q1 2024.
- Federated Hermes's portfolio value rose 7.8% quarter-over-quarter to $43.4B.
Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.